Generic prescribing: Time to regulate the market?: Price rises are a blow to nascent primary care groups

BMJ

Volumn 320, Issue 7228, 2000, Pages 131-132

  Walley, T ^a   Burrill, Peter ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

COST CONTROL; DRUG COST; EDITORIAL; HUMAN; MARKET; NATIONAL HEALTH SERVICE; PHARMACIST; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL;

DRUG COSTS; DRUGS, GENERIC; STATE MEDICINE;

EID: 0034651229     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.320.7228.131     Document Type: Editorial

References (7)

1. Department of Health. Statistics of prescriptions dispensed in the community: England 1988. Statistical Bulletin 1998/15.
2. NHS Executive. Quality and performance in the NHS: high level performance indicators. London: Department of Health, 1999.
3. Department of Health. Drug tariff. London: Stationary Office, 1999.
4. UK generics shortage is real, not imagined. Scrip 1999; 18 Aug: 5.
5. Patient pack prescribing and the provision of patient information leaflets. Drug Ther Bull 1995; 33: 86–88.
6. Health Select Committee. The cost and availability of generic drugs to the NHS. London: Stationary Office, 1999.
7. Cooper C. Generics crisis spreads. Medeconomics 1999; Dec: 11.